Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Neoplasms of the CNS

  Free Subscription


01.01.2020

3 AJNR Am J Neuroradiol
2 Am J Clin Oncol
4 BMC Cancer
1 BMC Neurol
1 Br J Cancer
2 Br J Neurosurg
1 Brain
1 Cancer Res
3 Childs Nerv Syst
3 Clin Cancer Res
5 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
13 J Neurooncol
1 J Neuropathol Exp Neurol
1 J Neurosurg
1 JAMA
2 Nat Rev Cancer
9 Neuro Oncol
4 Neurology
3 Neurosurgery
1 Oncogene
1 PLoS Biol
1 PLoS One
2 Proc Natl Acad Sci U S A
2 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. LEAO DJ, Craig PG, Godoy LF, da La Leite C, et al
    Response Assessment in Neuro-Oncology Criteria for Gliomas: Practical Approach Using Conventional and Advanced Techniques.
    AJNR Am J Neuroradiol. 2019 Dec 19. pii: ajnr.A6358. doi: 10.3174/ajnr.A6358.
    PubMed     Text format     Abstract available

  2. HAN W, Qin L, Bay C, Chen X, et al
    Deep Transfer Learning and Radiomics Feature Prediction of Survival of Patients with High-Grade Gliomas.
    AJNR Am J Neuroradiol. 2019 Dec 19. pii: ajnr.A6365. doi: 10.3174/ajnr.A6365.
    PubMed     Text format     Abstract available

  3. AZUMA M, Khant ZA, Kitajima M, Uetani H, et al
    Usefulness of Contrast-Enhanced 3D-FLAIR MR Imaging for Differentiating Rathke Cleft Cyst from Cystic Craniopharyngioma.
    AJNR Am J Neuroradiol. 2019 Dec 19. pii: ajnr.A6359. doi: 10.3174/ajnr.A6359.
    PubMed     Text format     Abstract available


    Am J Clin Oncol

  4. MURPHY B, Walker J, Bassale S, Monaco D, et al
    Concurrent Radiosurgery and Immune Checkpoint Inhibition: Improving Regional Intracranial Control for Patients With Metastatic Melanoma.
    Am J Clin Oncol. 2019;42:253-257.
    PubMed     Text format     Abstract available

  5. RYCKMAN JM, Surkar SM, Haque W, Butler EB, et al
    Sequencing of Chemotherapy and Radiotherapy for Newly Diagnosed Anaplastic Oligodendroglioma and Oligoastrocytoma.
    Am J Clin Oncol. 2019;42:258-264.
    PubMed     Text format     Abstract available


    BMC Cancer

  6. SUN C, Dai X, Zhao D, Wang H, et al
    Mesenchymal stem cells promote glioma neovascularization in vivo by fusing with cancer stem cells.
    BMC Cancer. 2019;19:1240.
    PubMed     Text format     Abstract available

  7. PERREAULT S, Larouche V, Tabori U, Hawkin C, et al
    A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.
    BMC Cancer. 2019;19:1250.
    PubMed     Text format     Abstract available

  8. LIU J, Jin B, Su H, Qu X, et al
    Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: a case report.
    BMC Cancer. 2019;19:702.
    PubMed     Text format     Abstract available

  9. ZAKRZEWSKA M, Gruszka R, Stawiski K, Fendler W, et al
    Expression-based decision tree model reveals distinct microRNA expression pattern in pediatric neuronal and mixed neuronal-glial tumors.
    BMC Cancer. 2019;19:544.
    PubMed     Text format     Abstract available


    BMC Neurol

  10. CHEN H, Li X, Zhang X, Xu W, et al
    Late delayed radiation-induced cerebral Arteriopathy by high-resolution magnetic resonance imaging: a case report.
    BMC Neurol. 2019;19:232.
    PubMed     Text format     Abstract available


    Br J Cancer

  11. SIMPSON AD, Soo YWJ, Rieunier G, Aleksic T, et al
    Type 1 IGF receptor associates with adverse outcome and cellular radioresistance in paediatric high-grade glioma.
    Br J Cancer. 2019 Dec 20. pii: 10.1038/s41416-019-0677.
    PubMed     Text format     Abstract available


    Br J Neurosurg

  12. MASUDA H, Nemoto M, Harada N, Fuchinoue Y, et al
    Comparison of quantitative measurements of central nervous system tumour consistency and the associated preoperative imaging findings.
    Br J Neurosurg. 2019;33:522-527.
    PubMed     Text format     Abstract available

  13. GASENZER ER, Kanat A, Ozdemir V, Rakici SY, et al
    Interesting different survival status of musicians with malignant cerebral tumors.
    Br J Neurosurg. 2019 Dec 18:1-7. doi: 10.1080/02688697.2019.1701629.
    PubMed     Text format     Abstract available


    Brain

  14. RECH F, Herbet G, Gaudeau Y, Mezieres S, et al
    A probabilistic map of negative motor areas of the upper limb and face: a brain stimulation study.
    Brain. 2019;142:952-965.
    PubMed     Text format     Abstract available


    Cancer Res

  15. BECKMANN PJ, Larson JD, Larsson AT, Ostergaard JP, et al
    Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors.
    Cancer Res. 2019;79:905-917.
    PubMed     Text format     Abstract available


    Childs Nerv Syst

  16. GIAGNACOVO M, Antonelli M, Biassoni V, Schiavello E, et al
    Retrospective analysis on the consistency of MRI features with histological and molecular markers in diffuse intrinsic pontine glioma (DIPG).
    Childs Nerv Syst. 2019 Dec 17. pii: 10.1007/s00381-019-04463.
    PubMed     Text format     Abstract available

  17. SAHINOGLU M, Karabagli P, Karabagli H, Koktekir E, et al
    Intraventricular microcystic meningioma in a child: a case report.
    Childs Nerv Syst. 2019 Dec 17. pii: 10.1007/s00381-019-04472.
    PubMed     Text format     Abstract available

  18. MUHAMMED A, Gaber MS, Elbeltagy M, El Hemaly A, et al
    Correction to: Risk stratification of pediatric high-grade glioma: a newly proposed prognostic score.
    Childs Nerv Syst. 2019 Dec 18. pii: 10.1007/s00381-019-04473.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  19. WU S, Gao F, Zheng S, Zhang C, et al
    EGFR amplification induces increased DNA damage response and renders selective sensitivity to Talazoparib (PARP inhibitor) in glioblastoma.
    Clin Cancer Res. 2019 Dec 18. pii: 1078-0432.CCR-19-2549.
    PubMed     Text format     Abstract available

  20. VAUBEL RA, Tian S, Remonde D, Schroeder MA, et al
    Genomic and phenotypic characterization of a broad panel of patient derived xenografts reflects the diversity of glioblastoma.
    Clin Cancer Res. 2019 Dec 18. pii: 1078-0432.CCR-19-0909.
    PubMed     Text format     Abstract available

  21. WORONIECKA KI, Rhodin KE, Dechant CA, Waibl Polania J, et al
    4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers.
    Clin Cancer Res. 2019 Dec 23. pii: 1078-0432.CCR-19-1068.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  22. YAN M, Laperriere N, Velec M, Bartels U, et al
    Redefining Ventricular Target Volume in Germinoma: Is Inclusion of Temporal Horns Necessary?
    Int J Radiat Oncol Biol Phys. 2019;104:852-858.
    PubMed     Text format     Abstract available

  23. BRENEMAN J, Laack NNI, MacDonald S, Ermoian R, et al
    Pediatric Radiation Therapy-When Too Much Is Not Enough.
    Int J Radiat Oncol Biol Phys. 2019;104:963-966.
    PubMed     Text format    

  24. ERMOIAN RP, Vitanza NA
    No Further Therapy.
    Int J Radiat Oncol Biol Phys. 2019;104:969-970.
    PubMed     Text format    

  25. LAACK NNI
    Spare the Rad, Spoil the Child (or Young Adult).
    Int J Radiat Oncol Biol Phys. 2019;104:969.
    PubMed     Text format    

  26. BITTERMAN DS, Chi SN, Haas-Kogan DA
    A Central Role of Radiation Therapy in Central Nervous System Germinoma.
    Int J Radiat Oncol Biol Phys. 2019;104:970-971.
    PubMed     Text format    


    J Clin Oncol

  27. SHUEN AY, Lanni S, Panigrahi GB, Edwards M, et al
    Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue.
    J Clin Oncol. 2019;37:461-470.
    PubMed     Text format     Abstract available


    J Neurooncol

  28. PATEL V, McNinch NL, Rush S
    Diagnostic delay and morbidity of central nervous system tumors in children and young adults: a pediatric hospital experience.
    J Neurooncol. 2019;143:297-304.
    PubMed     Text format     Abstract available

  29. LO AC, Laperriere N, Hodgson D, Bouffet E, et al
    Canadian patterns of practice for intracranial germ cell tumors in adolescents and young adults.
    J Neurooncol. 2019;143:289-296.
    PubMed     Text format     Abstract available

  30. GITTLEMAN H, Cioffi G, Vecchione-Koval T, Ostrom QT, et al
    Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.
    J Neurooncol. 2019;143:251-260.
    PubMed     Text format     Abstract available

  31. YOUSEF A, Rutkowski MJ, Yalcin CE, Eren OC, et al
    Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
    J Neurooncol. 2019;143:547-552.
    PubMed     Text format     Abstract available

  32. KO Y, Gwak HS, Park EY, Joo J, et al
    Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer.
    J Neurooncol. 2019;143:553-562.
    PubMed     Text format     Abstract available

  33. WINOGRAD E, Rivers CI, Fenstermaker R, Fabiano A, et al
    The case for radiosurgery for brainstem metastases.
    J Neurooncol. 2019;143:585-595.
    PubMed     Text format     Abstract available

  34. SONG LR, Weng JC, Huo XL, Wang L, et al
    Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas.
    J Neurooncol. 2019 Dec 18. pii: 10.1007/s11060-019-03372.
    PubMed     Text format     Abstract available

  35. CARSTAM L, Ryden I, Gulati S, Rydenhag B, et al
    Socioeconomic factors affect treatment delivery for patients with low grade glioma: a Swedish population-based study.
    J Neurooncol. 2019 Dec 27. pii: 10.1007/s11060-019-03378.
    PubMed     Text format     Abstract available

  36. BIKHEZAR F, de Kruijff RM, van der Meer AJGM, Torrelo Villa G, et al
    Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.
    J Neurooncol. 2019 Dec 24. pii: 10.1007/s11060-019-03365.
    PubMed     Text format     Abstract available

  37. GILANI A, Donson A, Davies KD, Whiteway SL, et al
    Targetable molecular alterations in congenital glioblastoma.
    J Neurooncol. 2019 Dec 24. pii: 10.1007/s11060-019-03377.
    PubMed     Text format     Abstract available

  38. KEREZOUDIS P, Goyal A, Lu VM, Alvi MA, et al
    The role of radiation and chemotherapy in adult patients with high-grade brainstem gliomas: results from the National Cancer Database.
    J Neurooncol. 2019 Dec 24. pii: 10.1007/s11060-019-03374.
    PubMed     Text format     Abstract available

  39. YOSHIDA A, Motomura K, Natsume A, Chalise L, et al
    Preoperative predictive factors affecting return to work in patients with gliomas undergoing awake brain mapping.
    J Neurooncol. 2019 Dec 18. pii: 10.1007/s11060-019-03371.
    PubMed     Text format     Abstract available

  40. MATSUI Y, Maruyama T, Nitta M, Saito T, et al
    Prediction of lower-grade glioma molecular subtypes using deep learning.
    J Neurooncol. 2019 Dec 21. pii: 10.1007/s11060-019-03376.
    PubMed     Text format     Abstract available


    J Neuropathol Exp Neurol

  41. PI CASTRO D, Jose-Lopez R, Fernandez Flores F, Rabanal Prados RM, et al
    Expression of FOXP3 in Canine Gliomas: Immunohistochemical Study of Tumor-Infiltrating Regulatory Lymphocytes.
    J Neuropathol Exp Neurol. 2019 Nov 11. pii: 5679984. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Neurosurg

  42. BERGER A, Tzarfati G, Costa M, Serafimova M, et al
    Incidence and impact of stroke following surgery for low-grade gliomas.
    J Neurosurg. 2019 Dec 27:1-9. doi: 10.3171/2019.10.JNS192301.
    PubMed     Text format     Abstract available


    JAMA

  43. ABBASI J
    Brain Cancer Triage Test Advances.
    JAMA. 2019;322:2161.
    PubMed     Text format    


    Nat Rev Cancer


  44. Focusing on brain tumours and brain metastasis.
    Nat Rev Cancer. 2020;20:1.
    PubMed     Text format    

  45. BRAY N
    Tumour cells co-opt synaptic signalling.
    Nat Rev Cancer. 2019;19:663.
    PubMed     Text format    


    Neuro Oncol

  46. JARAIZ-RODRIGUEZ M, Talaveron R, Garcia-Vicente L, Pelaz SG, et al
    Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth and enhances survival in mouse models in vivo.
    Neuro Oncol. 2019 Dec 28. pii: 5688710. doi: 10.1093.
    PubMed     Text format     Abstract available

  47. NASSIRI F, Zadeh G
    How should we manage incidental meningiomas?
    Neuro Oncol. 2019 Dec 25. pii: 5686813. doi: 10.1093.
    PubMed     Text format    

  48. XUE J, Wang B, Ming Y, Liu X, et al
    Deep-learning-based Detection and Segmentation-assisted Management on Brain Metastases.
    Neuro Oncol. 2019 Dec 23. pii: 5684915. doi: 10.1093.
    PubMed     Text format     Abstract available

  49. LANGEN KJ, Galldiks N, Lohmann P
    Combined FET PET/ADC mapping: improved imaging of glioma infiltration?
    Neuro Oncol. 2019 Dec 20. pii: 5681898. doi: 10.1093.
    PubMed     Text format    

  50. RUDA R, Soffietti R
    Does an Optimal Management of Brain Metastases from Oncogenic-Driver Non-Small Cell Lung Cancer Exist?
    Neuro Oncol. 2019 Dec 20. pii: 5681666. doi: 10.1093.
    PubMed     Text format    

  51. HUANG RY, Guenette JP
    Non-invasive Diagnosis of H3 K27M Mutant Midline Glioma.
    Neuro Oncol. 2019 Dec 20. pii: 5681667. doi: 10.1093.
    PubMed     Text format    

  52. CLOUGHESY TF, Brenner A, de Groot JF, Butowski NA, et al
    A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).
    Neuro Oncol. 2019 Dec 17. pii: 5679576. doi: 10.1093.
    PubMed     Text format     Abstract available

  53. BRENNER AJ, Peters KB, Vredenburgh J, Bokstein F, et al
    Safety and efficacy of VB-111, an anti-cancer gene-therapy, in patients with recurrent glioblastoma: results of a phase I/II study.
    Neuro Oncol. 2019 Dec 17. pii: 5679561. doi: 10.1093.
    PubMed     Text format     Abstract available

  54. HAIDER AS, van den Bent M, Wen PY, Vogelbaum MA, et al
    Towards a standard pathological and molecular characterization of recurrent glioma in adults: a RANO effort.
    Neuro Oncol. 2019 Dec 17. pii: 5679607. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neurology

  55. NOWOSIELSKI M, Gorlia T, Bromberg JEC, Sahm F, et al
    Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study.
    Neurology. 2019 May 10. pii: WNL.0000000000007643.
    PubMed     Text format     Abstract available

  56. YOUNG AS, Jonker B, Welgampola MS
    Vestibular paroxysmia presenting with irritative nystagmus.
    Neurology. 2019;92:723-724.
    PubMed     Text format    

  57. DIAS AB, Cambruzzi E, Giugno CS, Miranda de Curtis R, et al
    Teaching NeuroImages: Intracranial malignant triton tumor: An uncommon location of a rare tumor.
    Neurology. 2019;92:e1401-e1402.
    PubMed     Text format    

  58. RUFF MW, Uhm JH, Benarroch EE
    Neuro-oncology: Implications of the molecular era.
    Neurology. 2019;92:568-574.
    PubMed     Text format     Abstract available


    Neurosurgery

  59. GARDNER P
    Commentary: Acquired Personality Disturbances After Meningioma Resection Are Strongly Associated With Impaired Quality of Life.
    Neurosurgery. 2019 Dec 30. pii: 5689360. doi: 10.1093.
    PubMed     Text format    

  60. KHATRI D, Patel NV, Reichman N, Langer DJ, et al
    Commentary: The Correlation of Fluorescence of Protoporphyrinogen IX and Status of Isocitrate Dehydrogenase in Gliomas.
    Neurosurgery. 2019 Dec 24. pii: 5686212. doi: 10.1093.
    PubMed     Text format    

  61. MANDONNET E, Herbet G, Duffau H
    Letter: Introducing New Tasks for Intraoperative Mapping in Awake Glioma Surgery: Clearing the Line Between Patient Care and Scientific Research.
    Neurosurgery. 2019 Dec 19. pii: 5680678. doi: 10.1093.
    PubMed     Text format    


    Oncogene

  62. GREEN AL, DeSisto J, Flannery P, Lemma R, et al
    BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway.
    Oncogene. 2019 Dec 16. pii: 10.1038/s41388-019-1125.
    PubMed     Text format     Abstract available


    PLoS Biol

  63. PORTELA M, Venkataramani V, Fahey-Lozano N, Seco E, et al
    Glioblastoma cells vampirize WNT from neurons and trigger a JNK/MMP signaling loop that enhances glioblastoma progression and neurodegeneration.
    PLoS Biol. 2019;17:e3000545.
    PubMed     Text format     Abstract available


    PLoS One

  64. BERENS ME, Sood A, Barnholtz-Sloan JS, Graf JF, et al
    Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas.
    PLoS One. 2019;14:e0219724.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  65. FLORES-TORO JA, Luo D, Gopinath A, Sarkisian MR, et al
    CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
    Proc Natl Acad Sci U S A. 2019 Dec 26. pii: 1910856117.
    PubMed     Text format     Abstract available

  66. STREITBERGER KJ, Lilaj L, Schrank F, Braun J, et al
    How tissue fluidity influences brain tumor progression.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1913511116.
    PubMed     Text format     Abstract available


    Radiology

  67. PARK JE, Kim HS, Park SY, Nam SJ, et al
    Prediction of Core Signaling Pathway by Using Diffusion- and Perfusion-based MRI Radiomics and Next-generation Sequencing in Isocitrate Dehydrogenase Wild-type Glioblastoma.
    Radiology. 2019 Dec 17:190913. doi: 10.1148/radiol.2019190913.
    PubMed     Text format     Abstract available

  68. RUDIE JD, Rauschecker AM, Bryan RN, Davatzikos C, et al
    Emerging Applications of Artificial Intelligence in Neuro-Oncology.
    Radiology. 2019;290:607-618.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: